SecBot SecBot
SECBOTREPLAY Home › Report › TCRX

TCRX · TScan Therapeutics announced the resignation of Leiden Dworak as Vice…

TScan Therapeutics, Inc. · 8-K filed Apr 2, 2026 at 07:30 ET

At the news

NEUTRALIMPACT 3/10

8-K filed Apr 2, 2026 at 07:30 ET

TScan Therapeutics announced the resignation of Leiden Dworak as Vice President of Finance and principal accounting officer, effective April 10, 2026. Jason A. Amello, the company's CFO, has been appointed as the new principal accounting officer without additional compensation.

  • Leiden Dworak resigned as Vice President of Finance and principal accounting officer effective April 10, 2026.
  • Jason A. Amello, current CFO and principal financial officer, was appointed as principal accounting officer effective April 10, 2026.
  • No disagreements were reported between the company and Mr. Dworak regarding operations, policies, or practices.
  • Mr. Amello will not receive additional compensation for taking on the expanded role.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access